Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


5th Ocular Diseases Drug Discovery

21 Mar 2013 - 22 Mar 2013 - San Francisco, USA



Bookmark and Share


The Ocular Diseases & Drug Development Conference taking place on March 21-22, 2013 in San Francisco, CA is now in its fifth year. As chairperson and moderator, I look forward to attending this conference. It continues to offer presentations on novel and innovative therapeutics in ocular drug development and discovery. This year we are fortunate to have Dr. Samir Patel, CEO and President of Ophthotech, as our keynote speaker. A leader in the field, Dr. Patel, a trained retina specialist, will present data from his recent clinical studies on a new and adjunct treatment for wet AMD, Fovista. We have two panels at this year's conference: 1) a safety regulatory panel with experts in the field being moderated by Dr. Ken Mandell and 2) a VC/ BD panel being moderated by Dr. Emmett Cunningham. This forum allows for excellent networking, the exchange of ideas, and sharing of challenges; all with a united common goal of bringing new and innovative treatments to patients in the area of ophthalmology.

The conference features the following topics:

Session: Novel Targets, Developments and Technologies

Session: Novel Drug Delivery Methods to the Anterior and Posterior Segments

Session: Clinical Development Advances & Updates 

Session: Safety Assessment and Regulatory Landscape in Ocular Drug Development

Session: Short Presentations

Panel Discussion: BD, Investments and Potential for Collaborations

Panel Discussion: Safety and Regulatory in Ocular Development



Further information
Scientific News
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Faster UVA Molecular Analysis Technology
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level.
Scientists Synthesize Anti-Cancer Agent
A team led by Rice University synthetic organic chemist K.C. Nicolaou has developed a new process for the synthesis of a series of potent anti-cancer agents originally found in bacteria.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!